European Journal of Clinical and Biomedical Sciences

Volume 7, Issue 2, April 2021

  • Tobacco Snuff Induced Comparative Weight Changes and Notable Physical Observations in Adults Albino Wistar Rats

    Chima Innocent Ugbor, Chidiebere Cyprian Vitus Eloka, Charles Ikechukwu Ezema, Uchechukwu Anthonia Ezeugwu, Benson Eihebholoria Omijie, Solomon Nwanze Ekoh, Basil Nnaemeka Obodo, Kenneth Emeka Udeme

    Issue: Volume 7, Issue 2, April 2021
    Pages: 21-26
    Received: 28 August 2020
    Accepted: 13 October 2020
    Published: 22 March 2021
    Abstract: In Nigeria, tobacco snuff is the powdered form of smokeless tobacco blended with potash as its main additive. It has been discovered to have several adverse health effects, though perceived by many as safe. In this eight-week study, the effect of tobacco snuff consumption on body weight, physical observation and growth performance of Wistar rats we... Show More
  • A Cross-sectional Survey of Job Stress Among Nurses Working at National Hospital Trauma Centre, Abuja, Nigeria

    Onyedika Godfrey Okoye, Oluwole Olayemi Olaomi, Uchenna Elizabeth Okoye, Uduak-Enimose Onaghise

    Issue: Volume 7, Issue 2, April 2021
    Pages: 27-32
    Received: 16 April 2021
    Accepted: 3 May 2021
    Published: 14 May 2021
    Abstract: Background: Job stress is recognized world-wide as a major challenge to workers’ health and their organizations. This study is intended to determine the work stress among nurses working in a Nigerian dedicated trauma centre. Methods: This is a cross-sectional study carried out at the trauma centre of a Nigerian tertiary institution from August to N... Show More
  • Establishment of Microbial Limit Test for Hospital Preparation ‘Compound Alum Powder’

    Fangming Tan, Minna Huang, Suishan Qiu, Zhuanzhi Liang

    Issue: Volume 7, Issue 2, April 2021
    Pages: 33-36
    Received: 22 April 2021
    Accepted: 11 May 2021
    Published: 21 May 2021
    Abstract: Background: the assessment of microbiological quality of medicinal products is one of control stages in medicinal products saft, because the holder of a manufacturing authorization must drug so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorization and do not place patients at risk due to ... Show More